Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Treatment of Migraine”

222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 222 results

Testing effectiveness (Phase 2)Study completedNCT00293657
What this trial is testing

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

Who this might be right for
Headache (Migraine)
POZEN 150
Post-approval studies (Phase 4)Study completedNCT00297375
What this trial is testing

A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine Headache

Who this might be right for
MigraineHead PainHeadache
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 375
Testing effectiveness (Phase 2)Study completedNCT00319137
What this trial is testing

An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine

Who this might be right for
Migraine DisordersMigraine
GlaxoSmithKline 126
Large-scale testing (Phase 3)Study completedNCT01989936
What this trial is testing

Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan

Who this might be right for
Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 446
Large-scale testing (Phase 3)Looking for participantsNCT05125302
What this trial is testing

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Who this might be right for
Migraine
AbbVie 1,059
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07577050
What this trial is testing

A Phase II Study of NB001 for Acute Migraine Treatment

Who this might be right for
Migraine
Chinese PLA General Hospital 120
Not applicableStudy completedNCT06680206
What this trial is testing

Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey

Who this might be right for
Migraine
Pfizer 1,395
Large-scale testing (Phase 3)Study completedNCT00812006
What this trial is testing

Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis

Who this might be right for
Migraine
Organon and Co 108
Large-scale testing (Phase 3)Study completedNCT00898677
What this trial is testing

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)

Who this might be right for
Migraine Headache
Organon and Co 1,268
Large-scale testing (Phase 3)Study completedNCT02439320
What this trial is testing

Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:

Who this might be right for
Acute Migraine
Eli Lilly and Company 2,231
Not applicableEnded earlyNCT04089761
What this trial is testing

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Who this might be right for
Acute Migraine
Theranica 60
Large-scale testing (Phase 3)Study completedNCT01001234
What this trial is testing

Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

Who this might be right for
Migraine, Acute
Organon and Co 1,382
Large-scale testing (Phase 3)Study completedNCT03526874
What this trial is testing

Occipital Blocks for Acute Migraine

Who this might be right for
Chronic Migraine, HeadacheEpisodic Migraine
Children's Hospital of Philadelphia 63
Testing effectiveness (Phase 2)Study completedNCT01430442
What this trial is testing

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Who this might be right for
MigraineAcute Treatment of Migraine
Pfizer 1,026
Large-scale testing (Phase 3)Study completedNCT00483704
What this trial is testing

Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)

Who this might be right for
Migraines
Merck Sharp & Dohme LLC 1,935
Not applicableWithdrawnNCT03787238
What this trial is testing

A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine (REAL)

Who this might be right for
Migraine
ElectroCore INC
Large-scale testing (Phase 3)Study completedNCT00442936
What this trial is testing

Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)

Who this might be right for
Migraine
Merck Sharp & Dohme LLC 1,380
Large-scale testing (Phase 3)Study completedNCT03461757
What this trial is testing

Trial in Adult Subjects With Acute Migraines

Who this might be right for
Migraine, With or Without Aura
Pfizer 1,811
Large-scale testing (Phase 3)Study completedNCT03275922
What this trial is testing

Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE

Who this might be right for
Migraine
Impax Laboratories, LLC 374
Testing effectiveness (Phase 2)Study completedNCT00483717
What this trial is testing

Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine

Who this might be right for
Migraine
Egalet Ltd 173
Load More Results